Group Psychedelic-Assisted Therapy in the ACT
A future-focused, evidence-based mental health solution β led by ACT-trained professionals and supported by emerging science.
π Why Now?
- β Traditional Medicare sessions fall short: Short-term CBT doesn't meet the needs of people with complex trauma and depression.
Watters et al., 2022 β MJA - π Mental health costs are rising: Group psychedelic therapy reduces burden on GPs and emergency departments.
Schenberg, 2018 β Frontiers in Pharmacology - π Waitlists are at breaking point: System-wide modelling shows the current approach is unsustainable.
Hall et al., 2022 β Australian Health Review
π‘ What Makes Group Psychedelic Therapy Different?
- π§ Targets root causes, not symptoms: Promotes emotional breakthroughs in trauma-focused care.
Ross et al., 2016 β J Psychopharm - π€ Group formats amplify healing: Peer support, community connection, and cost efficiency.
Wagner et al., 2021 β TAPP - π₯ Reduces pressure on the system: Safe, scalable, and locally deliverable in clinical settings.
TGA Special Access Pathways
π¨ Write to Your Local MLA Today
Use our quick form to find your MLA and generate a ready-to-send letter of support.
π©ββοΈ Supported by ACTβs Mind MedicineβTrained Professionals
Psychiatrists, social workers, GPs, trauma counsellors and nurses in the ACT are trained, registered, and ready to deliver this care under TGA pathways.
π Explore the national directory of trained practitioners:
Visit the Mind Medicine Australia Practitioner Directory β
π¬ Find out more, ask questions, and help advance this innovative therapy model for those who need it most.
